Engineers Gate Manager LP Revolution Medicines, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$30.14 - $40.68 $1.05 Million - $1.42 Million	34,951 Added 311.84%	46,159 $1.79 Million
Q1 2024 May 15, 2024	BUY	$26.56 - $33.55 $297,684 - $376,028	11,208 New	11,208 $361,000
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $1.36 Million - $1.9 Million	54,082 New	54,082 $1.5 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $590,663 - $856,120	28,452 New	28,452 $616,000
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $433,471 - $604,687	-18,099 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $524,871 - $858,616	18,099 New	18,099 $574,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.